AJOONI vs ORKLAINDIA: Stock Comparison

AJOONI BIOTECH vs ORKLA INDIAUpdated 15 Sept 26, 3:00 PM ISTNSE & company filings

ORKLA INDIA is the larger company by market capitalisation. AJOONI BIOTECH shows faster revenue growth, while ORKLA INDIA shows a higher ROE, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AJOONI leads 2; ORKLAINDIA leads 8 of 11

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AJOONIORKLAINDIA

Valuation lens

What price are you paying?

Market CapContext only
₹59 Cr
₹7,952 Cr
P/E RatioSame reading
27.37x
P/B RatioSame reading
2.93x
EPSORKLAINDIA has the higher reading
₹0.25
₹6.4
Book ValueContext only
₹4.81
₹200.75
Dividend YieldSame reading
0%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
ORKLAINDIA is the larger company
₹7,952 Cr vs ₹59 Cr
EPS
ORKLAINDIA has higher earnings per share
₹6.4 vs ₹0.25
Revenue Growth (TTM YoY)
AJOONI has faster revenue growth
103.3% vs 5%
EPS Growth (TTM YoY)
ORKLAINDIA has faster EPS growth
107.7% vs -44.4%
Qtr Sales Growth
AJOONI has stronger quarterly sales growth
4.73% vs 2.31%
Qtr Profit Growth
ORKLAINDIA has stronger quarterly profit growth
1.54% vs -54.41%
ROE
ORKLAINDIA has a higher ROE
10.39% vs 4.74%
ROCE
ORKLAINDIA has a higher ROCE
10.67% vs 4.49%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAJOONIORKLAINDIA
SectorFast Moving Consumer GoodsFast Moving Consumer Goods
IndustryAnimal FeedOther Food Products

Price

MetricAJOONIORKLAINDIA
Live Price₹3.42₹580.7
Day Change-1.44%-1.78%
Volume2.89 L26,727
52-Week High₹5.94₹760
52-Week Low₹3.4₹533.25
Distance from 52W High-42.42%-23.59%

Valuation

MetricAJOONIORKLAINDIA
Market Cap₹59 Cr₹7,952 Cr
P/E Ratio27.37x
P/B Ratio2.93x
EPS₹0.25₹6.4
Book Value₹4.81₹200.75
Dividend Yield0%0%

Growth

MetricAJOONIORKLAINDIA
Revenue Growth (TTM YoY)103.3%5%
EPS Growth (TTM YoY)-44.4%107.7%
Qtr Sales Growth4.73%2.31%
Qtr Profit Growth-54.41%1.54%

Profitability & Leverage

MetricAJOONIORKLAINDIA
ROE4.74%10.39%
ROCE4.49%10.67%
Net Margin2.34%9.35%
Operating Margin3.55%15.53%
Debt to Equity0.19x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAJOONIORKLAINDIA
Promoter Holding26.89%75%
FII Holding0%2.3% 0.12 pp
DII Holding0%8.69% 0.05 pp
Public Holding73.11%14% 0.15 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AJOONI BIOTECH and ORKLA INDIA.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.